Lika Apriani

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

Dick Menzies, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 368 citations · Full text

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

Rovina Ruslami, Ahmad Rizal Ganiem, Sofiati Dian et al. · The Lancet Infectious Diseases · 2012 · 343 citations

Pulmonary Tuberculosis, Health Sciences, Clinical Infection +9

Safety and Side Effects of Rifampin versus Isoniazid in Children

Thierno Diallo, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 155 citations · Full text

<i>Mycobacterium tuberculosis</i>Beijing Genotype Is an Independent Risk Factor for Tuberculosis Treatment Failure in Indonesia

Ida Parwati, Bachti Alisjahbana, Lika Apriani et al. · The Journal of Infectious Diseases · 2010 · 81 citations · Full text

Early Clearance of Mycobacterium tuberculosis Is Associated With Increased Innate Immune Responses

Ayesha J Verrall, Marion Schneider, Bachti Alisjahbana et al. · The Journal of Infectious Diseases · 2019 · 81 citations